ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

954-synchronous-peritoneal-carcinomatosis-from-a-buccal-squamous-cell-carcinoma-a-case-report-focusing-on-possible-metastatic-mechanisms-and-novel-therapeutic-modalities

Case Report: Synchronous peritoneal carcinomatosis from a buccal squamous cell carcinoma: a case report focusing on possible metastatic mechanisms and novel therapeutic modalities

Frank S Fan, Chung-Fan Yang

29 Jul 2019

https://doi.org/10.3332/ecancer.2019.954

Abstract | Full Article | PDF

904-womens-cancers-how-the-discovery-of-brca-genes-is-driving-current-concepts-of-cancer-biology-and-therapeutics

Review: Women’s cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics

Pooja Murthy, Franco Muggia

14 Feb 2019

https://doi.org/10.3332/ecancer.2019.904

Abstract | Full Article | PDF

900-ros1-mutation-non-small-cell-lung-cancer-access-to-optimal-treatment-and-outcomes

Research: ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Amit Joshi, Nikhil Pande, Vanita Noronha, Vijay Patil, Rajiv Kumar, Anuradha Chougule, Trivedi Vaishakhi, Amit Janu, Abhishek Mahajan, Kumar Prabhash

29 Jan 2019

https://doi.org/10.3332/ecancer.2019.900

Abstract | Full Article | PDF

898-access-to-high-cost-drugs-for-advanced-breast-cancer-in-latin-america-particularly-trastuzumab

Special Issue: Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab

Carlos Henrique Barrios, Tomás Reinert, Gustavo Werutsky

22 Jan 2019

https://doi.org/10.3332/ecancer.2019.898

Abstract | Full Article | PDF | Spanish

896-precision-medicine-for-locally-advanced-breast-cancer-frontiers-and-challenges-in-latin-america

Special Issue: Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Joseph A Pinto, César H Saravia, Claudio Flores, Jhajaira Araujo, David Martínez, Luis J Schwarz, Alberto Casas, Leny Bravo, Jenny Zavaleta, Brigitte Chuima, Hober Alvarado, Ricardo Fujita, Henry L Gómez

22 Jan 2019

https://doi.org/10.3332/ecancer.2019.896

Abstract | Full Article | PDF | Spanish

891-proteomics-characterisation-of-central-nervous-system-metastasis-biomarkers-in-triple-negative-breast-cancer

Research: Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

Katerin Rojas L, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Cristina Chiva, Juan Sepúlveda, Luis Manso, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Rocío López-Vacas, María Ferrer-Gómez, César Mendiola, Enrique Espinosa, Eduard Sabidó, Eva Ciruelos, Juan Ángel Fresno Vara

15 Jan 2019

https://doi.org/10.3332/ecancer.2019.891

Abstract | Full Article | PDF